Life360, Inc. (NASDAQ:LIF – Get Free Report) Director Mark Goines sold 10,000 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $43.89, for a total transaction of $438,900.00. Following the completion of the transaction, the director now owns 66,272 shares in the company, valued at $2,908,678.08. The trade was a 13.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Mark Goines also recently made the following trade(s):
- On Friday, November 22nd, Mark Goines sold 50,000 shares of Life360 stock. The stock was sold at an average price of $40.70, for a total transaction of $2,035,000.00.
Life360 Trading Up 6.7 %
LIF opened at $49.45 on Friday. The business’s 50-day moving average price is $42.78. Life360, Inc. has a 12-month low of $26.00 and a 12-month high of $49.50.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on Life360
Institutional Trading of Life360
Institutional investors and hedge funds have recently bought and sold shares of the business. Regal Partners Ltd acquired a new position in shares of Life360 in the second quarter valued at approximately $23,635,000. XY Capital Ltd acquired a new position in shares of Life360 in the second quarter worth $205,000. Emerald Mutual Fund Advisers Trust purchased a new stake in shares of Life360 during the second quarter worth $5,488,000. Emerald Advisers LLC acquired a new stake in shares of Life360 in the second quarter valued at $6,777,000. Finally, Point72 DIFC Ltd purchased a new position in Life360 in the second quarter valued at $43,000.
Life360 Company Profile
Life360 Inc is a family connection and safety company. Its business category includes mobile app and Tile tracking devices with a range of services, including location sharing, safe driver reports and crash detection with emergency dispatch. Life360 Inc is based in SAN FRANCISCO.
Featured Articles
- Five stocks we like better than Life360
- How to Invest in the FAANG Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Breakout Stocks: What They Are and How to Identify Them
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Tickers Leading a Meme Stock Revival
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Life360 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life360 and related companies with MarketBeat.com's FREE daily email newsletter.